What is Immix Biopharma, Inc.'s gross realized gains?

Immix Biopharma, Inc. (IMMX) reported gross realized gains of $10.65K in Q1 2026.

Immix Biopharma, Inc. IMMX Gross realized gains

Gross realized gains at other companies

Bank7 Corp.BSVN

$0—

Citizens Financial Services, Inc.CZFS

$0—

USCB Financial Holdings, Inc.USCB

$82K—

Trustco Bank CorpTRST

$0—

Employers HoldingsEIG

$15.48M+1,090%

American Resources Investment Trust IncINV

$0-100%

Other financials

Income statement

See full

Operating income-$10.8M-131%

Net income-$10.1M-122%

EPS (diluted)-$0.18-20.0%

Balance sheet

See full

Cash & equivalents$79.3M+398%

Total debt$1.0M-2.0%

Total equity$84.4M+779%

Total assets$95.8M+382%

Cash flow

See full

Operating cash flow-$9.8M-483%

CapEx$32.5K-52.0%

Free cash flow-$9.9M-462%

Valuation

See full

Market cap$691.97M+1,008%

Enterprise value$613.75M+1,190%

Returns & leverage

See full

Return on equity-74.4%-18.6pp

Debt / equity0×-0.1×

Current ratio8.8×+7.0×

Where this comes from

Reported directly by Immix Biopharma, Inc. in its filing.

Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleRealizedGain.

The official record: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Immix Biopharma, Inc.'s gross realized gains.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Immix Biopharma, Inc.'s gross realized gains?: Immix Biopharma, Inc. (IMMX) reported gross realized gains of $10.65K in Q1 2026.